Register Financial Advisors’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$467	–	425
2024 Q2	$467	Hold	100	–	–	﹤0.01%	710
2024 Q1	$742	Buy	+100	New	+$831	﹤0.01%	707

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Register Financial Advisors's EDIT Position: Q3 2024 in Review

Register Financial Advisors sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 100 shares — an estimated $467 sold.

Register Financial Advisors first reported a position in EDIT in Q1 2024 and held it in 2 quarters. The position peaked at $742 in Q1 2024. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

Register Financial Advisors reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
Register Financial Advisors sold 100 Editas Medicine shares in Q3 2024, an estimated $467.
Register Financial Advisors first reported a position in Editas Medicine in Q1 2024 and held it in 2 quarters.
Register Financial Advisors's Editas Medicine position peaked at $742 in Q1 2024.
229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Register Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.